M06.341

Clinical Causes: Autoimmune response: The body's immune system mistakenly targets joint tissues, leading to inflammation and nodule formation. Genetic factors: A family history of rheumatoid arthritis increases susceptibility to developing nodules. Severity of rheumatoid arthritis: More aggressive disease often results in nodule formation. Environmental factors: Smoking and exposure to certain environmental triggers can contribute to nodule development. Duration of disease: Longer-standing rheumatoid arthritis has a higher likelihood of extra-articular manifestations such as nodules.

Key Symptoms: Firm, subcutaneous lumps: Typically non-tender and moveable underneath the skin. Location-specific: Commonly found near affected joints—here, predominantly on the right hand. Size variability: Ranges from small pea-sized bumps to larger lumps. Potential skin changes: Overlying skin may appear reddened or inflamed in some cases. Rare symptoms: If the nodules ulcerate or become infected, they may cause additional discomfort or complications.

Diagnosis Path: Diagnosis primarily involves physical examination to identify the characteristic nodules near the right hand joints. Imaging tests such as X-rays or ultrasound can help assess the nodules and rule out other conditions. A biopsy may be performed if there is uncertainty about the nature of the lumps. Rheumatoid disease activity is typically evaluated through blood tests, measuring markers like rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) antibodies, alongside clinical assessment.

Treatment Protocols: Disease-modifying antirheumatic drugs (DMARDs): Medications like methotrexate or hydroxychloroquine to control immune response. Biologic agents: Such as TNF inhibitors, which can decrease nodule size and reduce inflammation. Corticosteroids: May be used to reduce inflammation temporarily in affected areas. Surgical removal: Considered if the nodules cause pain, functional impairment, or recurrent ulceration. Monitoring: Regular check-ups to track disease progression and nodule development.